CTRI/2021/07/035113尚未招募未知
COMPARATIVE STUDY OF SAFETY AND EFFICACY OF THREE DIFFERENT DOSES OF FENTANYL ON HEMODYNAMIC RESPONSE TO LARYNGOSCOPY AND TRACHEAL INTUBATION IN PATIENTSâ?? UNDER GENERAL ANAETHESIA.
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. American Society of Anaethesiology (ASA) grade I and II
- •2. Patients posted for elective surgery under GA requiring endotracheal intubation.
- •3.Hemodynamically stable patients with all routine investigationswithin normal limits.
- •4. Availability of informed consent.
排除标准
- •1.Patients with ASA physical status III or more.
- •2. Patients with major neurological, cardiac, respiratory, metabolic, renal, hepatic disease or with coagulation abnormalities.
- •3. Patients with anticipated difficult intubation.
- •4. Patients with known allergies to the study drug.
- •5. Patients who are not giving consent for above study.
- •6 .Patients with body mask index more than 30.
- •7.Patients posted for emergency procedure.
- •8. Pregnant patients.
研究者
相似试验
进行中（未招募）
不适用
ASSESSMENT OF THE EFFICACY AND SAFETY OF THREE CONCENTRATIONS: 1%, 0.3%, 0.1% OF CD5024 CREAM ONCE DAILY AND CD5024 1% CREAM TWICE DAILY, VERSUS ITS VEHICLE AND VERSUS METRONIDAZOLE 0.75% CREAM (ROZEX®), IN PATIENTS WITH PAPULO-PUSTULAR ROSACEA OVER 12 WEEKSPatients with papulo-pustular rosaceaMedDRA version: 9.0Level: LLTClassification code 10039218EUCTR2006-001999-20-CZGalderma Research & Development SNC270
进行中（未招募）
不适用
ASSESSMENT OF THE EFFICACY AND SAFETY OF THREE CONCENTRATIONS: 1%, 0.3%, 0.1% OF CD5024 CREAM ONCE DAILY AND CD5024 1% CREAM TWICE DAILY, VERSUS ITS VEHICLE AND VERSUS METRONIDAZOLE 0.75% CREAM (ROZEX®), IN PATIENTS WITH PAPULO-PUSTULAR ROSACEA OVER 12 WEEKSEUCTR2006-001999-20-HUGalderma Research & Development SNC270
进行中（未招募）
不适用
ASSESSMENT OF THE EFFICACY AND SAFETY OF THREE CONCENTRATIONS: 1%, 0.3%, 0.1% OF CD5024 CREAM ONCE DAILY AND CD5024 1% CREAM TWICE DAILY, VERSUS ITS VEHICLE AND VERSUS METRONIDAZOLE 0.75% CREAM (ROZEX®), IN PATIENTS WITH PAPULO-PUSTULAR ROSACEA OVER 12 WEEKSPatients with papulo-pustular rosaceaMedDRA version: 9.0Level: LLTClassification code 10039218EUCTR2006-001999-20-DEGalderma Research & Development SNC274
尚未招募
2 期
Evaluation and comparison of the efficacy of triple therapies regimens containing esomeprazole and different doses of amoxicillin and bismuth for eradicating Helicobacter pylori infection in SariIRCT20210518051335N1Mazandaran University of Medical Sciences200
已完成
不适用
The study on the effectiveness of three Protecting on the infantile colic paiColic in infants.Other and unspecified abdominal painIRCT2017102514333N84Vice chancellor for research, Esfahan University of Medical Sciences100